Male Breast Carcinoma Active Not Recruiting Phase 3 Trials for Goserelin (DB00014)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02115282Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticTreatment